Ayvakit is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Blueprint Medicines Corporation. The primary component is Avapritinib.
Product ID | 72064-130_5bb10e23-7d74-4b45-86aa-190ef4467b54 |
NDC | 72064-130 |
Product Type | Human Prescription Drug |
Proprietary Name | Ayvakit |
Generic Name | Avapritinib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-01-09 |
Marketing Category | NDA / NDA |
Application Number | NDA212608 |
Labeler Name | Blueprint Medicines Corporation |
Substance Name | AVAPRITINIB |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA],Bile Salt Export Pump Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2020-01-09 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212608 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-01-09 |
Ingredient | Strength |
---|---|
AVAPRITINIB | 300 mg/1 |
NDC | Brand Name | Generic Name |
---|---|---|
72064-110 | Ayvakit | avapritinib |
72064-120 | Ayvakit | avapritinib |
72064-125 | Ayvakit | avapritinib |
72064-130 | Ayvakit | avapritinib |
72064-150 | Ayvakit | avapritinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AYVAKIT 88589364 not registered Live/Pending |
Blueprint Medicines Corporation 2019-08-22 |
AYVAKIT 88478478 not registered Live/Pending |
Blueprint Medicines Corporation 2019-06-18 |